Metabolic network is related to surgical outcome in temporal lobe epilepsy with hippocampal sclerosis: A brain FDG-PET study

J Neuroimaging. 2022 Mar;32(2):300-313. doi: 10.1111/jon.12941. Epub 2021 Oct 22.

Abstract

Background and purpose: The aim of this study was to investigate differences in metabolic networks based on preoperative fluorodeoxyglucose (FDG)-positron emission tomography (PET) in temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS) between patients with complete seizure-free (SF) and those with noncomplete seizure-free (non-SF) after anterior temporal lobectomy.

Methods: This study was retrospectively performed at a tertiary hospital. We recruited pathologically confirmed 75 TLE patients with HS who underwent preoperative FDG-PET. All patients underwent a standard anterior temporal lobectomy. The surgical outcome was evaluated at least 12 months after surgery, and we divided the subjects into patients with SF (International League Against Epilepsy [ILAE] class I) and those with non-SF (ILAE class II-VI). We evaluated the metabolic network using graph theoretical analysis based on FDG-PET. We investigated the differences in network measures between the two groups.

Results: Of the 75 TLE patients with HS, 32 patients (42.6%) had SF, whereas 43 patients (57.3%) had non-SF. There were significant differences in global metabolic networks according to surgical outcomes. The patients with SF had a lower assortative coefficient than those with non-SF (-0.020 vs. -0.009, p = .044). We also found widespread regional differences in local metabolic networks according to surgical outcomes.

Conclusion: Our study demonstrates significant differences in preoperative metabolic networks based on FDG-PET in TLE patients with HS according to surgical outcomes. This work introduces a metabolic network based on FDG-PET and can be used as a potential tool for predicting surgical outcome in TLE patients with HS.

Keywords: PET; epilepsy; network.

MeSH terms

  • Brain / metabolism
  • Epilepsy, Temporal Lobe* / diagnostic imaging
  • Epilepsy, Temporal Lobe* / surgery
  • Fluorodeoxyglucose F18*
  • Hippocampus / diagnostic imaging
  • Hippocampus / metabolism
  • Hippocampus / surgery
  • Humans
  • Magnetic Resonance Imaging / methods
  • Metabolic Networks and Pathways
  • Positron-Emission Tomography / methods
  • Retrospective Studies
  • Sclerosis / diagnostic imaging
  • Sclerosis / pathology
  • Sclerosis / surgery
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18